Experimental drug may protect brain from radiation side effects
CLEVELAND, Ohio — Whole brain radiotherapy saves lives by treating cancer that has spread to the brain, but it also causes long-standing brain damage. Many patients who go through whole brain ...
F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...
Pharmabiz
Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint
Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...
Le Lézard
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary endpoint, showing clinically ...
The Manila Times
[Ad hoc announcement pursuant to Art. 53 LR] Roche's fenebrutinib confirms its potential as first and only BTK inhibitor for relapsing and primary progressive MS in third ...
FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...
Opinion
The Nation on MSNOpinion
An Unlawful War
The precedent being set by the US in launching this war of aggression against Iran will long live in infamy. Richard Falk On February 28, Trump embarked on a war against Iran, deliberately targeting ...
Reader's Digest Canada on MSN
13 silent signs of dementia (and how to spot them early)
From sudden personality changes to poor financial decision-making, here are the 13 early signs of dementia you should never ignore. The post 13 Silent Signs of Dementia (and How to Spot Them Early) ...
Everyday Health on MSN
How brensocatib (Brinsupri) treats bronchiectasis
Brensocatib, the first FDA-approved medication to treat non-cystic fibrosis bronchiectasis, can reduce symptoms of the chronic lung condition by targeting inflammation.
Campus Times
A look inside the Gorbunova-Seluanov Lab: Studying the science behind aging to improve human health
The Gorbunova-Seluanov Lab, led by URochester’s Doris Johns Cherry Professor of Biology and Medicine Vera Gorbunova, as well ...
FDA official calls UniQure's Huntington's disease treatment a failure
By Michael Erman and Puyaan Singh March 5 (Reuters) - A senior FDA official called UniQure's experimental treatment for ...
Fierce Biotech
UniQure shares crash 40% as FDA rejects early approval path for Huntington's gene therapy
Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...
FDA vaccine chief to leave the agency again
For the second time in less than a year, Vinay Prasad, the head of the U.S. Food and Drug Administration’s vaccines unit, is ...